HME ASH 2020
Logo HME Forum

62nd ASH Annual Meeting

5-8 December 2020
Please note that you must sign up for each broadcast to be able to view the on – demand version.
You can sign up here:
The evolving management of patients with multiple myeloma: a preview of ASH 2020
1 December 2020

The evolving management of patients with multiple myeloma: a preview of ASH 2020

In a virtual environment it is often a challenge to navigate the vast online congress programs. Join us for this live interactive broadcast when our expert faculty will preview the virtual American Society of Hematology (ASH) 2020 congress and discuss their anticipated highlights relating to the management of patients with multiple myeloma.

 

Learning objective:

After participating in this broadcast you should ...

more info...

EM-43697
Newly diagnosed multiple myeloma updates at ASH 2020: How can we integrate the latest data into patient management?
14 December 2020

Newly diagnosed multiple myeloma updates at ASH 2020: How can we integrate the latest data into patient management?

Learning objective:

After participating in this broadcast you should be able to:

  • Discuss the potential impact of data presented at the American Society of Hematology (ASH) 2020 congress on the management of patients with newly diagnosed multiple myeloma

 

Moderator:

  • Mohamad Mohty (France)

 

Faculty:

  • Philippe Moreau (France)
  • Francesca Gay (Italy)
more info...

EM-43698
Management of patients with CLL: Will the data from ASH 2020 change clinical practice?
15 December 2020

Management of patients with CLL: Will the data from ASH 2020 change clinical practice?

Learning objective:

After participating in this broadcast you should be able to:

  • Evaluate the potential impact of data presented at the American Society of Hematology (ASH) 2020 congress on the management of patients with chronic lymphocytic leukemia

 

Moderator:

  • John Gribben (UK)

 

Faculty:

  • Gianluca Gaidano (Italy)
  • Steve Coutre (US)
  • Carol Moreno (Spain)
more info...

EM-43699
Relapsed/refractory multiple myeloma updates at ASH 2020: How can we integrate the latest data into patient management?
16 December 2020

Relapsed/refractory multiple myeloma updates at ASH 2020: How can we integrate the latest data into patient management?

Learning objective:

After participating in this broadcast you should be able to:

  • Discuss the potential impact of data presented at the American Society of Hematology (ASH) 2020 congress on the management of patients with relapsed/refractory multiple myeloma

 

Moderator:

  • Mohamad Mohty (France)

 

Faculty:

  • Meletios Dimopoulos (Greece)
  • Michel Delforge (Belgium)
more info...

EM-43700
Updates from ASH 2020 relating to the management of patients with B-cell lymphomas
17 December 2020

Updates from ASH 2020 relating to the management of patients with B-cell lymphomas

Learning objective:

After participating in this broadcast you should be able to:

  • Summarize the data presented at the American Society of Hematology (ASH) 2020 congress relating to the management of patients with B-cell lymphomas

 

Moderator:

  • Christian Buske (Germany)

 

Faculty:

  • George Hess (Germany)
  • Steve Le Gouill (France)
more info...

EM-43701